<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neither intrathecal <z:chebi fb="0" ids="44185">methotrexate</z:chebi> nor posterior reversible <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> syndrome has previously been reported to result in mesial temporal <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Described here is the case of a boy with no risk factors for mesial temporal <z:mp ids='MP_0000612'>sclerosis</z:mp> who presented with posterior reversible <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> syndrome and partial complex <z:hpo ids='HP_0001250'>seizures</z:hpo> 8 days after initiation of intrathecal <z:chebi fb="0" ids="44185">methotrexate</z:chebi> for treatment of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and who ultimately progressed to intractable <z:e sem="disease" ids="C0014556" disease_type="Disease or Syndrome" abbrv="tle">temporal lobe epilepsy</z:e> due to left mesial temporal <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
</text></document>